| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.041 | 0.4 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.04 | 0.4 |